Miguel A.
López Pérez
Harvard Medical School
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Harvard Medical School (2)
2019
-
MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance
Diabetes, Vol. 68, Núm. 12, pp. 2210-2222
2016
-
Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone–induced liver damage through inflammation and endoplasmic reticulum stress
Hepatology, Vol. 64, Núm. 4, pp. 1086-1104